AstraZeneca PLC Earnings
The next earnings date for AstraZeneca PLC has not yet been scheduled.
Analyst Estimates of AstraZeneca PLC Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
AstraZeneca PLC Earnings: Historical
| 07/27/2026 | Before Market | $2.63 | 5.20% |
| 04/29/2026 | Before Market | $1.29 | 1.57% |
| 11/06/2025 | Before Market | $1.19 | 5.31% |
| 07/29/2025 | Before Market | $0.79 | -10.23% |
| 04/29/2025 | Before Market | $1.25 | 11.61% |
| 02/06/2025 | Before Market | $1.05 | 0.96% |
| 11/12/2024 | Before Market | $1.04 | 0.97% |
| 07/25/2024 | Before Market | $0.99 | 0.00% |
| 04/25/2024 | Before Market | $1.03 | 8.42% |
| 02/08/2024 | Before Market | $0.73 | -3.95% |
More About AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
“AstraZeneca PLC Earnings” Can Refer to the AstraZeneca PLC Earnings Date
Some people say “AstraZeneca PLC earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my AstraZeneca PLC position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning AstraZeneca PLC Stock on the Earnings Date
If you own AstraZeneca PLC stock (AZN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for AstraZeneca PLC might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading AstraZeneca PLC shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Owning AstraZeneca PLC Options on the Earnings Date
If you own AstraZeneca PLC options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
In addition, the extrinsic values of AstraZeneca PLC options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own AstraZeneca PLC options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.
This makes sense considering that prices are often more volatile on earnings dates for AstraZeneca PLC. That potential volatility is a key factor that affects the premium cost of owning options.
Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of AstraZeneca PLC options often go down. This is sometimes referred to as volatility crush.
Learning More AstraZeneca PLC Earnings
You can contact us any time if you would like to ask questions about AstraZeneca PLC earnings or anything else related to the stock market.